Protein Kinase C Inhibitors: Rationale for Use and Potential in the Treatment of Bipolar Disorder

Author： Zarate Carlos A. Manji Husseini K.

ISSN： 1172-7047

Source： CNS Drugs, Vol.23, Iss.7, 2009-07, pp. : 569-582

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Protein Kinase C Inhibitors in the Treatment of Diabetic Retinopathy. Review

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 3, 2011-01 ,pp. : 386-391

Bentham Science Publishers

Access to resources Recommend Favorite

Newer Antiepileptic Drugs in Bipolar Disorder: Rationale for Use and Role in Therapy

By Macdonald K.J. Young L.T.

CNS Drugs, Vol. 16, Iss. 8, 2002-01 ,pp. : 549-562

Adis International

Access to resources Recommend Favorite

Aminopyridines as protein kinase C&thgr; inhibitors

By Zhang Dawei

Expert Opinion on Therapeutic Patents, Vol. 17, Iss. 5, 2007-05 ,pp. : 583-586

Informa Healthcare

Access to resources Recommend Favorite

Protein kinase C inhibitors as novel anticancer drugs

By Jirousek Michael R Goekjian Peter G

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 12, 2001-12 ,pp. : 2117-2140

Informa Healthcare

Access to resources Recommend Favorite

Recent developments in protein kinase C inhibitors

By Harris W. Wilkinson S. Nixon J.

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 1, 1997-01 ,pp. : 63-68

Informa Healthcare

Access to resources Recommend Favorite